✦ LIBER ✦

Final results from a randomized phase 3 study of FOLFIRI panitumumab for second-line treatment of metastatic colorectal cancer

✍ Scribed by Peeters, M.; Price, T. J.; Cervantes, A.; Sobrero, A. F.; Ducreux, M.; Hotko, Y.; Andre, T.; Chan, E.; Lordick, F.; Punt, C. J. A.; Strickland, A. H.; Wilson, G.; Ciuleanu, T. E.; Roman, L.; Van Cutsem, E.; Tian, Y.; Sidhu, R.

Book ID: 121450110
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 350 KB
Volume: 25
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdt523

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Final results from PRIME: randomized pha

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

✍ Douillard, J. Y.; Siena, S.; Cassidy, J.; Tabernero, J.; Burkes, R.; Barugel, M. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 576 KB

14LBA Randomized phase 3 study of panitu

14LBA Randomized phase 3 study of panitumumab with FOLFIRI vs FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC)

✍ M. Peeters; T. Price; Y. Hotko; A. Cervantes; M. Ducreux; T. André; E. Chan; F. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

6083 Final results from PRECEPT: efficac

6083 Final results from PRECEPT: efficacy and safety of second-line treatment with panitumumab and FOLFIRI in patients with metastatic colorectal cancer (mCRC)

✍ Cohn, A.; Smith, D.A.; Neubauer, M.A.; Richards, D.; Watkins, D.L.; Zhang, K.; Y 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

An Open-label, Single-arm, Phase 2 Trial

An Open-label, Single-arm, Phase 2 Trial of Panitumumab Plus FOLFIRI as Second-line Therapy in Patients with Metastatic Colorectal Cancer

✍ Allen L. Cohn; Grace C. Shumaker; Pankaj Khandelwal; David A. Smith; Marcus A. N 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 429 KB

Skin toxicity and quality of life in pat

Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study

✍ Josef Thaler, Meinolf Karthaus, Laurent Mineur, Richard Greil, Henry Letocha, Ra 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 226 KB

653 POSTER First line therapy of panitum

653 POSTER First line therapy of panitumumab, a fully human antibody, in combination with FOLFIRI for the treatment (txt) of metastatic colorectal cancer (mCRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB